Ultromics Company
They are building world-class diagnostic aids to help cardiologists вАФ powered by artificial intelligence. To date, they have developed the worldвАЩs most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.
Investors
%20.png)
Estimated Revenue:
$1M to $10M
Headquarters:
Oxford, Oxfordshire, United Kingdom
Founded Date:
2017-01-01
Last Funding Date:
2021-08-16
Industry:
Imaging
Investors Number:
13
Employee Number:
11-50
Funding Status:
Early Stage Venture
Total Funding:
58824943
Last Funding Type:
Series B
Technology:
HealthCare Administration